Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                         Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and
                                                    Alliances Profile
       Reference Code: GDPH133894D                                                                                                            Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      Biolex Therapeutics, Inc. (Biolex) is a biopharmaceutical company, engaged in the
                                                                                                              Biolex Therapeutics, Inc., Pharmaceuticals &
      development and commercialization of therapeutic proteins and monoclonal
                                                                                                              Healthcare, Key Facts
      antibodies based on its proprietary LEX system. Biolex has developed LEX system,
      a novel technology that genetically transforms the aquatic plant lemna to enable the                     Web Address                       www.biolex.com
      production of biologic product candidates. The strengths of LEX System includes
                                                                                                               Revenue (US$ million)                            NA
      production of complex proteins, complex protein folding, optimization of monoclonal
      antibodies, access to product candidates, reduced safety risk, reduced capital cost                      Number of Employees                                      106
      and facility timelines.                                                                                  GlobalData

      Financial Deals Landscape
        Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals                    Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013


                                                                                                                          3
                                                                                                          3



                                                                                           No. of Deals
                                                                                                                                          2      2        2
                                                                                                          2

                                                                                                                 1
                                                                                                          1

                                                                                                                                    0                               0
                                                                                                          0
                                                                                                               2007      2008   2009     2010   2011     2012    YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare,                         Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013

                         12     10                                                                        8          7
          No. of Deals




                         10                                                                                                     6
                                                                                           No. of Deals




                          8                                                                               6
                          6
                                                                                                          4
                          4              2                                                                                                2          2
                                                  1         1        1
                          2                                                                               2                                                     1
                          0
                              North    Europe   Asia-     Middle   South                                  0
                              Americ            Pacific    East     and                                         Infectio Oncolo         Cardiov Immun         Hemato
                                a                          and     Central                                         us      gy           ascular ology         logical
                                                          Africa   Americ                                       Disease                                       Disorde
                                                                     a                                                                                           rs



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals                                                                                Reference Code: GDPH133894D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                    Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .......................................................... 4
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................... 5
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013....................................................... 6
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................ 7
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................ 8
       Biolex Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details ........................................................................................... 10
          Venture Financing......................................................................................................................................................................... 10
             Biolex Therapeutics Secures $2.4 Million In Venture Financing................................................................................................ 10
             Biolex Therapeutics Secures $5.8 Million In Venture Financing................................................................................................ 11
             Biolex Therapeutics Raises $8.68 Million In Venture Financing ................................................................................................ 12
             Biolex Therapeutics Secures $10 Million In Venture Financing................................................................................................. 13
             Biolex Therapeutics Secures $60 Million In Series D Financing ............................................................................................... 14
             Biolex Therapeutics Secures $30 Million In Series C Financing ............................................................................................... 17
          Partnerships.................................................................................................................................................................................. 19
             MRC Technology Enters Into Co-Development Agreement With Biolex Therapeutics ............................................................. 19
          Licensing Agreements .................................................................................................................................................................. 21
             Biolex Therapeutics Enters Into Licensing Agreement With Octoplus....................................................................................... 21
          Asset Transactions ....................................................................................................................................................................... 22
             Biolex Therapeutics To Sell Rights For Locteron ...................................................................................................................... 22
             Synthon Acquires LEX System From Biolex Therapeutics ........................................................................................................ 23
       Biolex Therapeutics, Inc. - Key Competitors..................................................................................................................................... 25
       Key Employees ................................................................................................................................................................................ 26
       Locations And Subsidiaries ...........................................................................................................
				
DOCUMENT INFO
Description: Biolex Therapeutics, Inc. (Biolex) is a biopharmaceutical company, engaged in the development and commercialization of therapeutic proteins and monoclonal antibodies based on its proprietary LEX system. Biolex has developed LEX system, a novel technology that genetically transforms the aquatic plant lemna to enable the production of biologic product candidates. The strengths of LEX System includes production of complex proteins, complex protein folding, optimization of monoclonal antibodies, access to product candidates, reduced safety risk, reduced capital cost and facility timelines. Biolex' product pipeline includes locteron, a controlled release formulation of recombinant human alpha interferon developed for the treatment of hepatitis C; BLX-155, full-length recombinant plasmin (fibrinolysin) produced with the LEX System developed for the treatment of thrombosis and BLX-301, an anti-CD20 antibody incorporating the optimized glycosylation structure. Biolex Therapeutics, Inc. operates as a biopharmaceutical company. It offers Locteron, a controlled-release interferon Alfa for the treatment of hepatitis C; BLX-155, a thrombolytic or clot buster to dissolve blood clots; and BLX-301, an antibody for the treatment of B-cell lymphoma. Biolex Therapeutics, Inc. has a research and development collaboration with Merial Limited to produce veterinary vaccines. The company is headquartered at Pittsboro in North Carolina, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.